ARV-1802

N/A

Report date: 2023/03/18 18:52:55
NME

Base Information

Drug NameARV-1802
Drug Alias NameARV-1802
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionLeptin receptor antagonists
TargetsLeptin receptor
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesArrevus Inc
China Registration ClassN/A

Develop Information

Active CompaniesArrevus Inc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A